110 related articles for article (PubMed ID: 19151562)
1. [Clinical values of biomarkers in hematopoietic malignancies].
Kawaguchi T; Nosaka K
Gan To Kagaku Ryoho; 2009 Jan; 36(1):26-31. PubMed ID: 19151562
[TBL] [Abstract][Full Text] [Related]
2. [Hematopoietic malignancy (leukemia, malignant lymphoma, multiple myeloma)].
Nosaka K; Kawaguchi T
Nihon Rinsho; 2012 May; 70(5):835-9. PubMed ID: 22620009
[TBL] [Abstract][Full Text] [Related]
3. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients.
Meirow D; Hardan I; Dor J; Fridman E; Elizur S; Ra'anani H; Slyusarevsky E; Amariglio N; Schiff E; Rechavi G; Nagler A; Ben Yehuda D
Hum Reprod; 2008 May; 23(5):1007-13. PubMed ID: 18344563
[TBL] [Abstract][Full Text] [Related]
4. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
5. Significance of four MRD markers in MRD-based treatment strategy for childhood acute lymphoblastic leukemia.
Sawada A; Sakata N; Kishimoto T; Higuchi B; Koyama M; Kondo O; Sato E; Okamura T; Yasui M; Inoue M; Yoshioka A; Kawa K
Leuk Res; 2009 Dec; 33(12):1710-3. PubMed ID: 19596431
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic immunomodulation of hematopoietic malignancies.
Gattei V; Fonsatti E; Sigalotti L; Degan M; Di Giacomo AM; Altomonte M; Calabrò L; Maio M
Semin Oncol; 2005 Oct; 32(5):503-10. PubMed ID: 16210091
[TBL] [Abstract][Full Text] [Related]
7. A multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: Hematological malignancies, the unusual cause of pancytopenia in patients with brucellosis.
Sari I; Altuntas F; Hacioglu S; Kocyigit I; Sevinc A; Sacar S; Deniz K; Alp E; Eser B; Yildiz O; Kaynar L; Unal A; Cetin M
Am J Hematol; 2008 Apr; 83(4):334-9. PubMed ID: 18069671
[TBL] [Abstract][Full Text] [Related]
8. Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.
Basso G; Veltroni M; Valsecchi MG; Dworzak MN; Ratei R; Silvestri D; Benetello A; Buldini B; Maglia O; Masera G; Conter V; Arico M; Biondi A; Gaipa G
J Clin Oncol; 2009 Nov; 27(31):5168-74. PubMed ID: 19805690
[TBL] [Abstract][Full Text] [Related]
9. Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression.
Doubek M; Palasek I; Pospisil Z; Borsky M; Klabusay M; Brychtova Y; Jurcek T; Jeziskova I; Krejci M; Dvorakova D; Mayer J
Exp Hematol; 2009 Jun; 37(6):659-72. PubMed ID: 19463768
[TBL] [Abstract][Full Text] [Related]
10. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
11. [Immunophenotyping of haematologic malignancies].
Koehorst SG; Evers H; van Buul T; de Vries F; Haanen C
Ned Tijdschr Geneeskd; 2004 Sep; 148(38):1861-5. PubMed ID: 15497779
[TBL] [Abstract][Full Text] [Related]
12. Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma.
Andersen NS; Pedersen LB; Laurell A; Elonen E; Kolstad A; Boesen AM; Pedersen LM; Lauritzsen GF; Ekanger R; Nilsson-Ehle H; Nordström M; Fredén S; Jerkeman M; Eriksson M; Väärt J; Malmer B; Geisler CH
J Clin Oncol; 2009 Sep; 27(26):4365-70. PubMed ID: 19652064
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells in hematopoietic malignancies.
Jones RJ; Armstrong SA
Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):12-6. PubMed ID: 18162216
[TBL] [Abstract][Full Text] [Related]
14. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies.
Kanda J; Ichinohe T; Matsuo K; Benjamin RJ; Klumpp TR; Rozman P; Blumberg N; Mehta J; Sohn SK; Uchiyama T
Transfusion; 2009 Apr; 49(4):624-35. PubMed ID: 19170998
[TBL] [Abstract][Full Text] [Related]
15. [Autologous hematopoietic stem cell transplantation].
Nemet D
Acta Med Croatica; 2009 Jun; 63(3):219-25. PubMed ID: 19827349
[TBL] [Abstract][Full Text] [Related]
16. Successful mobilization of hematopoietic peripheral blood progenitor cells with paclitaxel-based chemotherapy as initial or salvage regimen in patients with hematologic malignancies.
Fernández A; De Arriba F; Rivera J; Heras I; Vicente V; Lozano ML
Haematologica; 2008 Sep; 93(9):1436-8. PubMed ID: 18641021
[No Abstract] [Full Text] [Related]
17. Immune reconstitution following myeloablative allogeneic hematopoietic stem cell transplantation: the impact of expanding CD28negative CD8+ T cells on relapse.
Yakoub-Agha I; Saule P; Magro L; Cracco P; Duhamel A; Coiteux V; Bruno B; Dufossé F; Jouet JP; Dessaint JP; Labalette M
Biol Blood Marrow Transplant; 2009 Apr; 15(4):496-504. PubMed ID: 19285638
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
Burke MJ; Cao Q; Trotz B; Weigel B; Kumar A; Smith A; Verneris MR
Pediatr Blood Cancer; 2009 Dec; 53(7):1289-94. PubMed ID: 19731318
[TBL] [Abstract][Full Text] [Related]
20. [Clinical uses of flow cytometry in hematological oncology].
D'Ostilio A; Ginaldi L; Marini L; Di Gennaro A; De Martinis M; Quaglino D
Recenti Prog Med; 1997 Apr; 88(4):157-65. PubMed ID: 9206811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
